Lianzi Wang
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Cancer-related molecular mechanisms research
Papers in
-
- Viral Infections and Vectors 3
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
-
- RNA modifications and cancer 4
- Cancer-related gene regulation 2
- Co-authors
- Shubing Zhang (9 shared papers)Huihui Wang (9 shared papers)Jiaqing Liu (3 shared papers)Tao Li (1 shared paper)Xian Wu (1 shared paper)Xuemei Li (2 shared papers)Yuanhong Xu (15 shared papers)Wei Wei (7 shared papers)
- Journals
- Frontiers in Cellular and Infection Microbiology (2 papers)Cancer Cell International (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Journal of Medical Virology (2 papers)International Journal of Biological Sciences (1 paper)
- Partner nations
- ChinaSaint Kitts and Nevis
In The Last Decade
Lianzi Wang
21 papers receiving 776 citations
Lianzi Wang's Hit Papers
Peers
Comparison fields: 5 of 96
- Infectious Diseases 275
- Cancer Research 117
- Molecular Biology 305
- Modeling and Simulation 17
- Neurology 46
Countries citing papers authored by Lianzi Wang
This map shows the geographic impact of Lianzi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianzi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianzi Wang more than expected).
Fields of papers citing papers by Lianzi Wang
This network shows the impact of papers produced by Lianzi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianzi Wang. The network helps show where Lianzi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lianzi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 340 | |
| 2 | Dynamic regulation and functions of mRNA m6A modification Hit paper breakdown → | 2022 | 154 |
| 3 | 2021 | 51 | |
| 4 | 2019 | 34 | |
| 5 | 2020 | 33 | |
| 6 | 2019 | 25 | |
| 7 | 2022 | 24 | |
| 8 | 2024 | 18 | |
| 9 | 2021 | 16 | |
| 10 | 2019 | 16 | |
| 11 | 2023 | 13 | |
| 12 | 2024 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2023 | 9 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2025 | 2 |
About Lianzi Wang
Lianzi Wang is a scholar working on Infectious Diseases, Molecular Biology, Cancer Research, Critical Care and Intensive Care Medicine and Oncology, having authored 22 papers that have together received 784 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Viral Infections and Vectors (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer-related gene regulation (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Mosquito-borne diseases and control (2 papers), Thermal Regulation in Medicine (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (275 citations), Cancer Research (117 citations), Molecular Biology (305 citations), Modeling and Simulation (17 citations) and Neurology (46 citations). Lianzi Wang has collaborated with scholars based in China and Saint Kitts and Nevis. Frequent co-authors include Shubing Zhang, Huihui Wang, Jiaqing Liu, Tao Li, Xian Wu, Xuemei Li, Yuanhong Xu, Wei Wei, Tao Li and Jilong Shen. Their work appears in journals such as Frontiers in Cellular and Infection Microbiology, Cancer Cell International, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Medical Virology and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.